Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Alopecia areata patients have eye issues and need regular eye exams.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Research on platelet-rich plasma is growing, focusing on joint repair and future trends in pain and regenerative medicine.

Diabetic patients need tailored cosmetic treatments for skin aging, with new therapies showing promise.

Alopecia Areata affects young adults more in high-income countries, especially females.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Lupus patients on TikTok feel isolated, face medical gaslighting, and prefer non-drug treatments.

The oral supplement improved hair loss in patients with telogen effluvium.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

BMI is not enough for assessing obesity in women; use more personalized tools.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Apremilast improved symptoms in patients with severe skin conditions.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

DPCP can help regrow hair in some people with severe alopecia.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

LLLT increases hair density and growth in AGA patients.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.